Full Text View
Tabular View
No Study Results Posted
Related Studies
Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion (HABENOX)
This study has been completed.
Study NCT00959621   Information provided by Helsinki University

First Received on July 21, 2009.   Last Updated on August 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Habitual Abortion
Additional conditions recognized in this trial
Abortion, Habitual
More general conditions related to this trial
Abortion, Spontaneous
Pregnancy Complications
Interventions listed in this trial
Aspirin
Klexane
Klexane and ASA
Additional drug interventions recognized in this trial
Dalteparin
Enoxaparin
Heparin, Low-Molecular-Weight
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anticoagulants
Antipyretics
Antirheumatic Agents
Cardiovascular Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Helsinki University
Oulu University Hospital, Oulu, Finland
Karolinska Hospital, Stockholm, Sweden
Leiden Hospital, Leiden, The Netherlands


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services